Campbell & Co Investment Adviser’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,020	Closed	-$477K	–	1003
2022 Q1	$477K	Buy	+4,020	New	+$477K	0.13%	294
2021 Q4	–	Sell	-2,500	Closed	-$347K	–	892
2021 Q3	$347K	Buy	+2,500	New	+$347K	0.11%	325